Dibyalochan Praharaj

Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease.

A. Duseja, A. Sanyal, R. Mehta, 2022, Metabolic syndrome and related disorders.

Adipocytokine profile in children with Kawasaki disease at a mean follow-up period of 5.5 years: A study from North India

A. Rawat, Surjit Singh, Anju Gupta, 2022, World Journal of Clinical Pediatrics.

Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial.

A. Duseja, M. Premkumar, N. Verma, 2021, Journal of clinical and experimental hepatology.

Acute-on-Chronic liver failure – A brief overview

B. Mallick, P. Nath, Dibyalochan Praharaj, 2023, Journal of Integrative Medicine and Research.

Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF - An Open Label Randomized Clinical Trial.

C. Ahuja, A. Duseja, Kamal Kajal, 2023, Journal of clinical and experimental hepatology.

Acute hepatitis in tropics: A rainbow of causes

A. Anand, Dibyalochan Praharaj, 2023, Indian Journal of Gastroenterology.

Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium.

Hai Helen Li, Chuanwu Zhu, P. Hayes, 2023, The lancet. Gastroenterology & hepatology.

Effect of Nonalcoholic Fatty Liver Disease (NAFLD) on COVID-19: A Single-Center Study of 3983 Patients With Review of Literature

Y. Chawla, A. Duseja, S. Acharya, 2022, Cureus.

Vaccination Strategies for a Liver Transplant Recipient

Dibyalochan Praharaj, M. Sahu, Ajeet Singh Bhadouria, 2024, Journal of Clinical and Experimental Hepatology.